Category: ROOT

Meet the leaders of One GI

One GI is a management services organization that provides support for gastroenterologists in Kentucky, Indiana, Mississippi, Ohio and Tennessee.

Montecito Medical acquires Tampa medical office building with ASC

Montecito Medical has acquired a 16,500-square-foot medical office building in Tampa, Fla., that is currently leased to an ASC and the Reproductive Medicine Group of Tampa. 

2 recent ASC acquisitions

Here are two ASC acquisitions that Becker’s has reported on since May 16:

Blue Cross Blue Shield potentially cutting ties with Ascension ASCs

A contract between Blue Cross Blue Shield of Texas and Austin-based Ascension Texas is set to expire Jan. 31, forcing 10 Texas hospitals, 10 ASCs, two medical centers and 32 hospital-based clinics out of network, according to a Jan. 4 report from MySan…

Walgreens, CVS plan to dispense abortion pills

After the FDA said it would allow some retail pharmacies to dispense prescribed abortion pills, Walgreens and CVS told Becker’s they plan to distribute the drug mifepristone. 

FTC moves to ban noncompete agreements

The Federal Trade Commission proposed a rule that could lift wages by nearly $300 billion per year economy-wide by making it illegal for companies to block their employees from working for a competitor, The New York Times reported Jan. 5.

Mayo Clinic picks up stake in startup making pill-sized robot

Rochester, Minn.-based Mayo Clinic has obtained a stake in Endiatx, a startup making a pill-sized robot to diagnose digestive conditions, under a know-how licensing agreement with the company.

GI Alliance adds 2 leaders to board

GI Alliance, a Southlake, Texas-based GI practice management company, has appointed Kelly Robison and Paul Mango to its board.

4 recent ASC acquisitions, partnerships

Here are four ASC acquisitions and partnerships that Becker’s has reported on since Dec. 1:

Walgreens Boots Alliance reports $3.7B Q1 net loss

Walgreens Boots Alliance reported a $3.7 billion net loss in the first quarter of the 2023 fiscal year ending Nov. 30, a significant drop from $3.6 billion in net income over the same period last year, driven by after-tax charges for opioid-related cla…